Objective: Fear of cancer recurrence (FCR) is characterized by the fear, worry or concern that cancer will come back or progress. The negative effects associated with FCR are consistently identified by cancer survivors as one of their most prominent unmet needs. Current measures of FCR can be long, complex and burdensome for survivors to complete. The objective of the present study is to develop and validate a one-item measure of FCR.Methods: The ability of the FCR-1 to detect change in FCR over time was analyzed using a repeated-measures ANOVA and paired-samples t-tests. Pearson correlations were used to measure the concurrent, convergent and discriminant validity of the FCR-1, and a ROC analysis was conducted to determine an optimal clinical cut-off score.Results: The FCR-1 was found to be responsive to change in FCR over time. It demonstrated concurrent validity with the FCRI (r = .395, P = .010), and convergent validity with the Mishel Uncertainty in Illness Scale (r = .493, P = .001) and the Reassurance Questionnaire (r = .325, P = .044). Discriminant validity was confirmed when the FCR-1 did not significantly correlate with unrelated measures. A ROC analysis pinpointed an optimal clinical cut-off score of 45.0. Conclusions:The FCR-1 is a promising tool that can be incorporated in clinical and research settings. Due to its brevity, the care needs of highly distressed patients can be met quickly and efficiently. In research settings, the FCR-1 can reduce the cognitive burden experienced by survivors. K E Y W O R D S breast cancer, cancer, fear of cancer recurrence, oncology, psycho-oncology, scale development, single-item measure, survivors, unmet needs, validation | BACKGROUNDAlthough nearly half of all Canadian women will be diagnosed with cancer during their lifetime, the majority of these women will survive their cancer due to early detection and advanced treatment options. 1 Despite good prognosis, many of these women will experience fear of cancer recurrence (FCR). At a 2-day colloquium at the University of Ottawa in 2015, researchers consensually defined FCR as the "fear, worry, or concern relating to the possibility that cancer will come back or progress." 2 FCR is very common, especially at the end of treatment; studies have demonstrated that it can affect anywhere between 22% and 96% of cancer survivors. 2-4 Survivors consistently include FCR in their top health-related concerns, and frequently identify help regarding FCR as one of their most prominent unmet needs in healthcare settings. 4-6 29:788-795. wileyonlinelibrary.com/journal/pon 4 | RESULTS | ResponsivenessOnly participants with FCR-1 scores at all 6 timepoints (n = 29) were included in the RM ANOVA analysis. The FCR-1 means at each session are summarized in Table 2. A repeatedmeasures ANOVA with a Greenhouse-Geisser correction was used as sphericity could not be assumed. The mean scores for FCR were statistically significantly different (F[3.425, 95.903] = 4.026, P = .007, η 2 = .126). Paired sample ttests were conducted to examine the dif...

Few studies have examined how breast cancer survivors experience an individually tailored group exercise program designed to help mitigate physical and psychosocial challenges and improve health outcomes. This research used qualitative interviews to provide insight into what motivates breast cancer survivors to join an exercise program, what they hope to gain from exercise programs, the barriers they experience to participation, and their overall satisfaction with the program. Thirty-three breast cancer survivors from Atlantic Canada completed semi-structured, qualitative interviews following the completion of a twelve-week supervised exercise program, and thematic analysis was applied to transcripts of the interviews. Our findings suggest of the participants generally enrolled in the program, in hopes of increasing energy levels and muscular strength, most reported increases in both outcomes by the end of the program, and obstacles to participation included fatigue, poor physical health, and access challenges.

Objective: In this study, we aimed to (1) assess the effectiveness of an intensive multimodal day treatment program in improving externalizing problems and function in elementary-age children and (2) examine 3 predictors of the treatment outcome (i.e., family functioning, baseline severity, and comorbid disorders). Methods: The sample included 261 children (80.9% boys) between ages of 5 and 12. A retrospective chart review, from 2013 to 2018, and a prospective chart review, from 2018 to 2019, were conducted to extract all relevant data for the present study. Parents and teachers provided reports on children’s externalizing problems (i.e., aggressive behavior, attention problems, and rule-breaking behavior) and their level of function across different domains. The level of family functioning was also reported by parents, while clinicians assessed children’s severity of disturbance and their diagnoses at intake. Results: Based on both parents’ and teachers’ reports, children showed significant improvement in their externalizing problems. Moreover, children showed functional improvement at home, at school, with peers, and in hobbies by the end of the program. Based on teacher’s reports, children with lower level of severity showed less improvement in their attention problems, and those with comorbid developmental problems showed less improvement in their aggressive and rule-breaking behaviors. Family functioning did not predict any treatment outcome. Conclusion: An intensive multimodal day treatment program was effective in reducing the symptoms of externalizing problems in elementary-age children. However, children with less severe difficulties and comorbid developmental problems showed less improvement in their externalizing problems.